Anson Capital Inc. Sells 8,572 Shares of Medical Properties Trust, Inc. (NYSE:MPW)

Anson Capital Inc. cut its holdings in Medical Properties Trust, Inc. (NYSE:MPW) by 22.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,923 shares of the real estate investment trust’s stock after selling 8,572 shares during the period. Anson Capital Inc.’s holdings in Medical Properties Trust were worth $125,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Lindbrook Capital LLC boosted its holdings in Medical Properties Trust by 112.1% in the 1st quarter. Lindbrook Capital LLC now owns 7,225 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 3,819 shares during the period. Versant Capital Management Inc boosted its holdings in Medical Properties Trust by 435.0% in the 2nd quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 6,482 shares during the period. Iron Horse Wealth Management LLC boosted its holdings in Medical Properties Trust by 166.7% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 5,000 shares during the period. Future Financial Wealth Managment LLC bought a new position in Medical Properties Trust in the 1st quarter worth approximately $38,000. Finally, Fidelis Capital Partners LLC bought a new position in Medical Properties Trust in the 1st quarter worth approximately $43,000. 71.79% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on MPW shares. StockNews.com cut shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Saturday, May 18th. Truist Financial increased their target price on shares of Medical Properties Trust from $4.50 to $5.00 and gave the stock a “hold” rating in a research note on Thursday, May 30th. BNP Paribas cut shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $6.00 to $4.00 in a research note on Tuesday, July 2nd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $5.00 target price on shares of Medical Properties Trust in a research note on Tuesday, May 14th. Three research analysts have rated the stock with a sell rating and eight have issued a hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $4.86.

Medical Properties Trust Stock Performance

Medical Properties Trust stock opened at $4.81 on Wednesday. The stock has a market cap of $2.89 billion, a P/E ratio of -2.17, a price-to-earnings-growth ratio of 0.68 and a beta of 1.28. The firm’s fifty day moving average price is $4.65 and its 200-day moving average price is $4.65. Medical Properties Trust, Inc. has a fifty-two week low of $2.92 and a fifty-two week high of $6.69. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.93 and a current ratio of 2.93.

Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.75). The company had revenue of $266.60 million for the quarter, compared to the consensus estimate of $259.53 million. The firm’s revenue for the quarter was down 21.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.48 EPS. On average, equities research analysts expect that Medical Properties Trust, Inc. will post 0.9 earnings per share for the current fiscal year.

Medical Properties Trust Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 10th. Shareholders of record on Monday, September 9th will be issued a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a yield of 6.65%. The ex-dividend date of this dividend is Monday, September 9th. Medical Properties Trust’s dividend payout ratio (DPR) is presently -27.03%.

Insiders Place Their Bets

In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the sale, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the sale, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Elizabeth N. Pitman sold 10,025 shares of the firm’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $4.98, for a total transaction of $49,924.50. Following the completion of the sale, the director now directly owns 68,653 shares in the company, valued at approximately $341,891.94. The disclosure for this sale can be found here. Insiders own 1.53% of the company’s stock.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.